Stop Developing Drugs for the Cancer That Killed My Mother
October 31, 2014
October 31, 2014 Illustration by Shout
Funding drug development for rare cancers can hurt patients.
Scientists need to abandon the assumption that every medical challenge must be overcome by a direct attack.
Click here to continue reading.
Molecular signatures of aging are changing how conservationists assess population health, resilience and risk.
Paul Mischel is championing the importance of odd rings of DNA in tumors — and their promise as targets for cancer therapy.